Jason Scott Slakter is CEO at Ohr Pharmaceutical Inc (OHRP). They have made 10 open-market trades across 1 company since 2015, most recently 2017-04-10.
CIK 0001173281
10 open-market purchases totalling $663K since 2015, never a sale. Across 10 scored buys the stock is down 13.0% at ninety days, and 17.0 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| OHRP | 1,067,898 | $5.8M |
Shares reported on the most recent Form 4, priced at the 2017-04-13 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 20% |
| Avg Move | -7.1% | -9.2% | -13.0% |
| Alpha | -7.7% | -10.4% | -17.0% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OHRP | BUY | 2017-04-10 | 2017-04-13 | $0.70 | $200K | -8.5% | -20.0% | -30.5% |
| OHRP | BUY | 2016-06-20 | 2016-06-21 | $2.85 | $25K | +1.5% | -3.5% | +0.4% |
| OHRP | BUY | 2016-05-25 | 2016-05-26 | $3.11 | $11K | -2.3% | -16.7% | -13.0% |
| OHRP | BUY | 2016-05-23 | 2016-05-25 | $3.15 | $89K | -2.8% | -13.0% | -11.1% |
| OHRP | BUY | 2016-04-11 | 2016-04-12 | $3.35 | $21K | +4.4% | -14.8% | -19.5% |
| OHRP | BUY | 2016-03-07 | 2016-03-09 | $3.63 | $23K | -8.3% | -4.0% | -12.0% |
| OHRP | BUY | 2016-02-22 | 2016-02-23 | $3.11 | $19K | +6.5% | -8.4% | -3.4% |
| OHRP | BUY | 2016-01-19 | 2016-01-20 | $3.62 | $23K | +9.8% | -13.7% | -3.4% |
| OHRP | BUY | 2015-12-07 | 2015-12-08 | $4.07 | $12K | -35.8% | -14.3% | -39.5% |
| OHRP | BUY | 2015-11-02 | 2015-11-04 | $3.00 | $39K | -35.8% | +0.8% | -38.2% |
| OHRP | BUY | 2015-02-06 | 2015-02-10 | $6.75 | $200K | -35.8% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.